enzalutamide
English edit
Etymology edit
From (b)enza(mide) + -lutamide (“nonsteroid antiandrogen”).
Noun edit
enzalutamide (uncountable)
- (pharmacology) A synthetic, non-steroidal pure antiandrogen developed for the treatment of metastatic castration-resistant prostate cancer.
- 2015 July 16, “Poly (A) Binding Protein Cytoplasmic 1 Is a Novel Co-Regulator of the Androgen Receptor”, in PLOS ONE[1], :
- Abiraterone and enzalutamide are newly approved drugs for CRPC patients; although, patients will still eventually relapse and the overall survival is prolonged only ~4–5 months after treatment with the AR signaling becoming active in most of these relapsed tumors.